Eleven Biotherapeutics

Eleven Biotherapeutics

Eleven Biotherapeutics

Eleven Biotherapeutics is focused on developing innovative protein-basedtherapeutics to improve human health and treat diseases.
Founded
2010
Raised
$63M
Follow us
Alexa global traffic share
21 Sep 2016

Eleven Biotherapeutics acquires Viventia Bio in all-stock deal

Seeking Alpha
+1